Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When shouldn't we retransplant?

Michael A Zimmerman1, R Mark Ghobrial

  • 1Department of Surgery, Division of Liver and Pancreas Transplantation, The Pfleger Liver Institute, The Dumont-UCLA Transplant Center, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA 90095-7054, USA.

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|October 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 2024 International Liver Transplant Society and International Liver Cancer Association Consensus Recommendations for Liver Transplantation for Liver Cancer.

Liver cancer·2026
Same author

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same author

Graft survival after liver transplantation using portable normothermic machine perfusion at a US center.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Evaluating the impact of neighborhood socioenvironmental burden on patient characteristics and survival in liver transplant recipients.

Frontiers in transplantation·2026
Same author

Cell cycle pathway alterations predict outcomes post-liver transplantation for hepatocellular carcinoma.

Frontiers in transplantation·2026
Same author

Liver transplantation in patients with history of extra-hepatic malignancies.

Frontiers in transplantation·2026
Same journal

Effect of postoperative synbiotics on bacterial infections after liver transplantation: A randomized double-blind placebo-controlled trial.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Long-term renal benefit of a biopsy-guided personalized calcineurin inhibitor-sparing regimen late after liver transplantation.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

REPLY: From detecting sarcopenia to guiding intervention-should bedside muscle assessment in cirrhosis be function-oriented rather than mass-oriented?

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Letter to the Editor: From detecting sarcopenia to guiding intervention-should bedside muscle assessment in cirrhosis be function-oriented rather than mass-oriented?

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Pre-transplant lipase elevation: A single-center study of clinically significant pancreatitis in liver transplant candidates.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Can FMN even the playing field? mitochondrial FMN during hypothermic oxygenated perfusion to guide liver utilization.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
See all related articles

Orthotopic liver retransplantation (re-OLT) within 8-30 days of primary transplant failure yields poor outcomes. Early re-OLT (within 7 days) is recommended, while late re-OLT requires caution in high-risk patients.

Area of Science:

  • Hepatology
  • Transplantation Surgery
  • Gastroenterology

Background:

  • Orthotopic liver retransplantation (re-OLT) is a complex procedure for primary liver graft failure.
  • Optimal timing and patient selection for re-OLT remain critical for improving outcomes.

Purpose of the Study:

  • To evaluate the impact of timing and patient factors on outcomes following liver retransplantation.
  • To identify criteria for cautioning or discouraging re-OLT in specific patient populations.

Main Methods:

  • Retrospective analysis of liver retransplantation cases.
  • Evaluation of outcomes based on time intervals post-primary transplantation (early, intermediate, late).
  • Assessment of patient comorbidities, MELD scores, and donor characteristics.

Related Experiment Videos

Main Results:

  • Liver re-OLT within 8-30 days of primary graft failure is associated with the worst outcomes.
  • Late re-OLT should be approached with caution in patients with MELD scores >25, mechanical ventilation, renal insufficiency, or advanced age.
  • Use of extended criteria or older donors, especially for recurrent disease, is discouraged.

Conclusions:

  • Timing is crucial for liver retransplantation success, with early re-OLT (within 7 days) favored over intermediate timing.
  • Careful patient selection is essential for late re-OLT, considering disease severity and comorbidities.
  • Development of predictive models and clear definitions for 'futile re-OLT' are needed to guide clinical decision-making.